Nicholas E Banovich
Overview
Explore the profile of Nicholas E Banovich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
2111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vannan A, Lyu R, Williams A, Negretti N, Mee E, Hirsh J, et al.
Nat Genet
. 2025 Feb;
57(3):647-658.
PMID: 39901013
Large-scale changes in the structure and cellular makeup of the distal lung are a hallmark of pulmonary fibrosis (PF), but the spatial contexts that contribute to disease pathogenesis have remained...
2.
McCall A, Gutor S, Tanjore H, Burman A, Sherrill T, Chapman M, et al.
Sci Transl Med
. 2025 Jan;
17(780):eadk8623.
PMID: 39772774
Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease in which repetitive epithelial injury and incomplete alveolar repair result in accumulation of profibrotic intermediate/transitional "aberrant" epithelial cell states. The...
3.
Perry A, Hadad N, Chatterjee E, Jimenez-Ramos M, Farber-Eger E, Roshani R, et al.
Cell Rep Med
. 2024 Dec;
5(12):101871.
PMID: 39657669
Hepatic steatosis is a central phenotype in multi-system metabolic dysfunction and is increasing in parallel with the obesity pandemic. We use a translational approach integrating clinical phenotyping and outcomes, circulating...
4.
Lehmann M, Krishnan R, Sucre J, Kulkarni H, Pineda R, Anderson C, et al.
Am J Respir Cell Mol Biol
. 2024 Nov;
PMID: 39499861
The urgent need for effective treatments for acute and chronic lung diseases underscores the significance of developing innovative preclinical human research tools. The 2023 ATS Workshop on Precision Cut Lung...
5.
Shirazi S, Negretti N, Jetter C, Sharkey A, Garg S, Kapp M, et al.
bioRxiv
. 2024 Sep;
PMID: 39253423
Lung injury in preterm infants leads to structural and functional respiratory deficits, with a risk for bronchopulmonary dysplasia (BPD) that in its most severe form is accompanied by pulmonary hypertension...
6.
Hasegawa Y, Franks J, Tanaka Y, Uehara Y, Read D, Williams C, et al.
Sci Adv
. 2024 Jul;
10(28):eadl4913.
PMID: 38985878
The pathophysiology of silicosis is poorly understood, limiting development of therapies for those who have been exposed to the respirable particle. We explored mechanisms of silica-induced pulmonary fibrosis in human...
7.
Wang D, Hadad N, Moss S, Lopez-Jimenez E, Johnson S, Maher T, et al.
bioRxiv
. 2024 Jun;
PMID: 38853935
Methods: We adopted three complementary approaches to explore the role of mLOY in the pathogenesis of PF. We used copy number on chromosome Y to estimate mLOY comparing patients in...
8.
Natri H, Del Azodi C, Peter L, Taylor C, Chugh S, Kendle R, et al.
Nat Genet
. 2024 Apr;
56(5):1034.
PMID: 38664563
No abstract available.
9.
Natri H, Del Azodi C, Peter L, Taylor C, Chugh S, Kendle R, et al.
Nat Genet
. 2024 Mar;
56(4):595-604.
PMID: 38548990
Common genetic variants confer substantial risk for chronic lung diseases, including pulmonary fibrosis. Defining the genetic control of gene expression in a cell-type-specific and context-dependent manner is critical for understanding...
10.
Brown C, Hibbard J, Alizadeh D, Blanchard M, Natri H, Wang D, et al.
Nat Med
. 2024 Mar;
30(5):1501.
PMID: 38514871
No abstract available.